[{"NetIncomeLossConverted_1_Q1_USD":-168911000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":-89529000.0,"CommonStockSharesOutstanding_0_Q1_shares":129891856.0,"StockholdersEquity_0_Q1_USD":650951000.0,"EarningsPerShareBasic_1_Q1_USD":-1.32,"Assets_0_Q1_USD":1135584000.0,"CommonStockSharesConverted_0_Q1_shares":129891856.0,"RevenuesConverted_1_Q1_USD":1976000.0,"Ticker":"VIR","CIK":"1706431","name":"VIR BIOTECHNOLOGY, INC.","OfficialName":"Vir Biotechnology Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"3076942595.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210506"}]